About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
IRRIV International Renal Research Institute Vicenza
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
F
Cytokine Removal Therapy: What Is Its Role in The Treatment of Sepsis?
By
38th Vicenza Course on AKI and CRRT
FEATURING
Fernando Sanchez Moran
By
38th Vicenza Course on AKI and CRRT
FEATURING
Fernando Sanchez Moran
103 views
February 3, 2021
0 Comments
Login to view comments.
Click here to Login
38th Vicenza Course on AKI and CRRT
15:47
38th Vicenza Course on AKI and CRRT
Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker in …
Feat.
C. Albert,
K. Doi
14:26
38th Vicenza Course on AKI and CRRT
Septic AKI: Can Dialysis Membranes Be Used as a Therapeutic Approach?
Feat.
V. Cantaluppi
11:50
38th Vicenza Course on AKI and CRRT
Procoagulant State with COVID-19: Do We Need to Adapt Anticoagulatio…
Feat.
A. G. Schneider
12:54
38th Vicenza Course on AKI and CRRT
Citrate vs. Heparin Anticoagulation in CRRT: What to Recommend?
Feat.
D. Khadzhynov
13:30
38th Vicenza Course on AKI and CRRT
The Clinical Path for CRRT NICU Adoption: How To Know When the Risks…
Feat.
S. Goldstein
18:52
38th Vicenza Course on AKI and CRRT
How CARPEDIEM Helps Increase Adoption of Continuous Renal Replacemen…
Feat.
E. Vidal
14:36
38th Vicenza Course on AKI and CRRT
Polymyxin B HemoPerfusion Therapy for Endotoxemia: Does it Have a Ro…
Feat.
S. Lucio Cutuli
15:54
38th Vicenza Course on AKI and CRRT
Cytokine Removal Therapy: What Is Its Role in The Treatment of Sepsi…
Feat.
F. Sanchez Moran
06:15
38th Vicenza Course on AKI and CRRT
79 y/o Male with Bacterial Septic Shock Treated With Renal Replaceme…
Feat.
F. Sanchez Moran
12:24
38th Vicenza Course on AKI and CRRT
Extra-Corporeal Blood Purification in Critically Ill Septic Patients…
Feat.
A. Armaganidis
17:40
38th Vicenza Course on AKI and CRRT
Endotoxic Shock and COVID-19: What Is The Role of Polymyxin B Hemope…
Feat.
S. De Rosa
17:47
38th Vicenza Course on AKI and CRRT
What Is the Use of Biomarkers for the Management of AKI In the Criti…
Feat.
L. G Forni
21:48
38th Vicenza Course on AKI and CRRT
Can Biomarkers Be Utilized in the Management of Cardiac Surgery Asso…
Feat.
D. T. Engelman
11:47
38th Vicenza Course on AKI and CRRT
Why Should We Utilize Continuous Venovenous Hemodialysis as Modality…
Feat.
A. G. Schneider
12:42
38th Vicenza Course on AKI and CRRT
Interventional Clinical Trial: Does Extracorporeal CO2 Improve Renal…
Feat.
V. Marco Ranieri
08:45
38th Vicenza Course on AKI and CRRT
The Unknown Relevance of Endotoxemia and Patients with COVID-19: Doe…
Feat.
D. Yamane
11:33
38th Vicenza Course on AKI and CRRT
Endotoxemia and COVID-19 Experiences From the Stony Brook University…
Feat.
S. Mallipattu
17:45
38th Vicenza Course on AKI and CRRT
Comparing AKI in Sepsis and AKI in Patients With COVID-19: What Are …
Feat.
P. Pickkers
17:36
38th Vicenza Course on AKI and CRRT
Overview of The World Registry for RRT: Can We Manipulate the Immune…
Feat.
S. Romagnoli
